Fresh2 Group Limited (FRES)

USD 1.15

(-2.54%)

Market Cap (In USD)

932.93 Thousand

Revenue (In USD)

12.04 Million

Net Income (In USD)

-101.89 Million

Avg. Volume

34.32 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.854-9.03
PE
-
EPS
-
Beta Value
1.279
ISIN
US03635R3057
CUSIP
-
CIK
1786511
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Haohan Xu
Employee Count
-
Website
https://fresh2.co
Ipo Date
2020-01-30
Details
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.